Immunotherapy, or the ability to use a person’s own immune system to fight cancer, is rising as a promising treatment option in cancer care. In our first episode of our Cancer HealthCasts miniseries, we talk to one of the fathers of successful immunotherapy, Dr. Steven Rosenberg, about how a study he’s leading is unveiling a new form of personalized immunotherapy using tumor-infiltrating lymphocytes to combat metastatic breast cancer.
Cancer HealthCast
34m listen
How Personalized Immunotherapy Can Help Combat Metastatic Breast Cancer
A recent NCI study explores new immunotherapy treatment for metastatic breast cancer.
-
Dr. Steven Rosenberg Surgery Branch Chief, Center for Cancer Research NCI
Related Content
-
Quantum, Workforce Issues Lead FDA’s Digital Transformation
The FDA is taking a proactive approach to its digital transformation efforts that its tech leaders highlighted in a new IT strategy.
14m listen -
Storytelling Miniseries: The Skill that Can Unite Cross-Generational Teams
The third episode in this Storytelling Miniseries for federal leaders discusses bridging gaps across generations in the workplace.
20m listen -
AI Startups Help Detect, Prevent Common Cancers in Women
Brittany Connors, SBIR director of investor relations at NCI, discussed how she is working with startups to develop the technology that better detects breast cancer and cervical cancer in their early stages.
23m listen -
How Emerging Tech Removes Burdens at Nation’s Borders for CBP Officers
CBP Acting Executive Assistant Commissioner Diane Sabatino discussed her vision for emerging technologies the agency is adopting at the nation’s ports.
23m listen
